About Adalimumab
            
            Class: | Monoclonal antibody (TNF inhibitor)  
Use: | Treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and plaque psoriasis  
Adult dose: | Initial dose of 80 mg subcutaneously, followed by 40 mg subcutaneously every other week starting one week after the initial dose  
Pediatric dose: | For pediatric patients with juvenile idiopathic arthritis or Crohn's disease, dosing varies; typically, 0.8 mg/kg (up
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (TNF inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and plaque psoriasis
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be kept at room temperature (up to 25°C or 77°F) for a maximum of 14 days before use
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: PFIZER EUROPE MA EEIG, BELGIUM
                    
                    
                    Package Size
                    2 Pre-filled Pens + 2 Alcohol pads
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 3670.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 80 mg subcutaneously, followed by 40 mg subcutaneously every other week starting one week after the initial dose
                    
                    
                        Pediatric Dose
                    
                    
                        For pediatric patients with juvenile idiopathic arthritis or Crohn's disease, dosing varies; typically, 0.8 mg/kg (up to a maximum of 40 mg) subcutaneously for children aged 2 years and older, with maintenance doses following specific guidelines
                    
                 
                
                
                    
                        Side Effects
                    
                    Injection site reactions, headache, increased risk of infections, nausea, abdominal pain, and rash
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Active infections (including tuberculosis), hypersensitivity to adalimumab or any component of the formulation, and concurrent use with other biologic DMARDs or live vaccines
         
        
        
            
                Important Warnings
            
            Risk of serious infections, malignancies, and hypersensitivity reactions; monitor for signs of infection; caution in patients with a history of recurrent infections or those with chronic infections
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.